Russian government to introduce mandatory drugs labeling
The Russian government has officially announced that it will introduce the practice of mandatory labeling of drugs in Russia, with the aim to start more active monitoring for their quality, reports The Pharma Letter’s local correspondent.
According to Veronika Skvortsova, Russia’s Health Minister, the introduction of the labeling practice will allow to automatically identify the way of the drug from the producer to the final consumer.
It is planned that the new practice will be introduced in several stages. The program will be officially launched on January 1, 2017, for expensive drugs, (which are part of Seven Diseases program) and will be extended to vital and essential drugs in 2018 and for all other drugs since 2019.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze